As of 2024-12-14, the EV/EBITDA ratio of Medifast Inc (MED) is 4.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Medifast's latest enterprise value is 94.30 mil USD. Medifast's TTM EBITDA according to its financial statements is 20.12 mil USD. Dividing these 2 quantities gives us the above Medifast EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 10.8x | 7.3x |
| Forward P/E multiples | 8.2x - 11.8x | 10.0x |
| Fair Price | 21.83 - 101.99 | 56.06 |
| Upside | 13.9% - 432.3% | 192.6% |
| Date | EV/EBITDA |
| 2024-12-12 | 5.60 |
| 2024-12-11 | 5.68 |
| 2024-12-10 | 6.10 |
| 2024-12-09 | 5.68 |
| 2024-12-06 | 5.18 |
| 2024-12-05 | 5.12 |
| 2024-12-04 | 5.00 |
| 2024-12-03 | 4.72 |
| 2024-12-02 | 5.06 |
| 2024-11-29 | 4.97 |
| 2024-11-27 | 4.84 |
| 2024-11-26 | 4.23 |
| 2024-11-25 | 4.39 |
| 2024-11-22 | 4.28 |
| 2024-11-21 | 4.22 |
| 2024-11-20 | 4.14 |
| 2024-11-19 | 3.69 |
| 2024-11-18 | 3.82 |
| 2024-11-15 | 4.13 |
| 2024-11-14 | 4.21 |
| 2024-11-13 | 4.91 |
| 2024-11-12 | 4.82 |
| 2024-11-11 | 4.83 |
| 2024-11-08 | 4.69 |
| 2024-11-07 | 5.08 |
| 2024-11-06 | 4.98 |
| 2024-11-05 | 5.36 |
| 2024-11-04 | 4.50 |
| 2024-11-01 | 4.37 |
| 2024-10-31 | 4.26 |
| 2024-10-30 | 4.43 |
| 2024-10-29 | 4.33 |
| 2024-10-28 | 3.97 |
| 2024-10-25 | 3.74 |
| 2024-10-24 | 3.86 |
| 2024-10-23 | 3.83 |
| 2024-10-22 | 3.67 |
| 2024-10-21 | 3.93 |
| 2024-10-18 | 4.12 |
| 2024-10-17 | 4.00 |
| 2024-10-16 | 4.05 |
| 2024-10-15 | 3.95 |
| 2024-10-14 | 3.70 |
| 2024-10-11 | 4.07 |
| 2024-10-10 | 4.06 |
| 2024-10-09 | 3.94 |
| 2024-10-08 | 4.31 |
| 2024-10-07 | 4.37 |
| 2024-10-04 | 4.30 |
| 2024-10-03 | 4.21 |